A phase 1 study to evaluate the effect of multiple doses of ABBV-722 on the pharmacokinetics of cocktail probe substrates of CYP3A and select transporters in healthy adult subjects

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.